Most digital transformation projects in pharma stall because the technology vendor does not understand GMP and the GMP consultant does not understand the technology. We sit at the intersection. Senior engineers who have validated aseptic fill-finish lines and built digital maturity roadmaps for commercial manufacturing. Same people. Same engagement.
You get one team that can move from URS to digital twin to PPQ without translating between disciplines. No handoff gaps. No "that is not my scope" conversations when a data integrity issue shows up in the middle of a CQV cycle.
Aseptic fill-finish lines carry the highest regulatory stakes in pharma manufacturing. They also carry the highest complexity when digitisation arrives. Isolator controls, vision inspection, line automation, packaging integration, data flow to your QMS. Each system GMP-critical. Each interface a potential compliance gap.
We map the full integration, design the validation approach, and teach your team to own it. The Scandinavian model. When we leave, your operators understand the system. Your QA team has the documentation. Your engineering group has the design rationale. Nothing walks out the door with the consultant.
Digital systems in GMP environments need the same validation rigour as physical ones. URS, IQ/OQ/PQ, change control, data integrity. The regulator will not accept "the software vendor handles that." We write the validation package that holds up to EU GMP Annex 11, FDA 21 CFR Part 11, and whatever comes next.
Every engagement produces a structured knowledge package for your internal team. SOPs, validation protocols, system design rationale, change control framework. Documented the way your next inspection will need to read it. The way your next hire will need to learn from it.
Send us a brief. Even a rough one. We respond within 24 hours with a named specialist and an honest assessment of what your digital maturity actually requires.